Based on existing studies, TCM has significantly improved the clinical symptoms of COVID-19 with comorbidities such as fever, fatigue, dry cough, anorexia and asthma, the absorption of lung lesions, shortened the duration of viral shedding and the course of disease. Conclusions TCM has great ...
COVID-19 is a highly spreadable viral infection, reported first in Wuhan, China in December 2019 which spreads worldwide later. The pathogen of this disease is SARS-CoV virus. World Health Organization announced first the name of this new disease and declared this outbreak as a Public Health ...
The general symptoms of COVID-19 include fever, sore throat, cough, lung infections, and, in severe cases, acute respiratory distress syndrome, sepsis, and death. SARSCoV-2 predominantly affects the lung, but it can also affect other organs such as the brain, heart, and gastrointestinal ...
The SARS-CoV-2 or COVID-19 virus is thought to have originated in bats then spread to humans, possibly by contaminated meat sold in China’s meat market. Symptoms of COVID-19 may involve multiple systems including respiratory, gastrointestinal, musculoskeletal, and neurologic. Respiratory symptoms...
“The number of patients may have hit a peak, but it does not mean that we can let down our guard just yet,” he said. It takes time to identify exactly when a patient began showing the first symptoms of COVID-19. As a result, it is possible that data available to the panel at...
Design, Setting, and Participants Big Ten COVID-19 Cardiac Registry principal investigators were surveyed for aggregate observational data from March 1, 2020, through December 15, 2020, on athletes with COVID-19. For athletes with myocarditis, presence of cardiac symptoms and details of cardiac tes...
Symptoms of COVID-19 include (but are not limited to): Dry cough Tiredness Runny nose Loss of taste or smell Muscle or joint pain Sore throat Headache Aches and pains Diarrhoea A rash on skin, or discolouration of fingers or toes
COVID-19 is a disease caused by SARS-CoV-2 capable of causing mild to severe infections in humans. Since its first appearance in China in December 2019, th
Conclusions Various demographic and clinical characteristics, such as male gender, advanced age, comorbidities, and symptoms, were risk factors for mortality in patients with cancer and COVID-19. Our findings suggest recent anti-cancer treatments do not increase mortality....
Results showed that the primary endpoint (i.e. overall improvement of COVID-19 by day 28) was met irrespective of the quartile of time delay to the start of use of the study drug from the onset of symptoms [21]. This finding argues that as long as the selection biomarker remains ...